Higher TOP2A expression has been related with proliferation and metastasis in kidney clear cell carcinoma, a type of cancer that exhibits a diverse therapeutic response to immune checkpoint inhibitors. This evidence concerns the gene TOP2A and clear cell renal carcinoma.